Research in Experimental Medicine

, Volume 187, Issue 4, pp 275–286 | Cite as

Tissue protection by allopurinol in the myocardial calcium paradox

  • A. N. Øksendal
  • K. A. Espnes
  • P. Jynge
Original Papers

Summary

The aim of the present study was to evaluate the protective properties of the xanthine oxidase inhibitor allopurinol in the myocardial calcium paradox. Two injury levels, minimal and total calcium paradox, caused by different volumes (5 ml and 45 ml) of calcium-free perfusion (5 min) prior to calcium repletion (15 min) were examined ± allopurinol (0.15 mmol/l) in the normothermic isolated rat heart model.

Allopurinol supplementation (5 min prior to, during and 5 min following Ca2+-free perfusion) had no effect upon tissue injury in the total calcium paradox, but afforded considerable protection as assessed by enzymatic, physiologic, and metabolic parameters in the minimal calcium paradox. When allopurinol was omitted during calcium repletion, tissue protection was less apparent. The presence of verapamil (2 µmol/l) in addition to allopurinol (5 min prior to, during, and 5 min following calcium depletion) afforded only a marginal further protection in the minimal calcium paradox.

It is concluded from the present study that tissue protection by allopurinol in the calcium paradox is limited to minimal or less severe calcium paradox models and that the protective action of allopurinol may indicate an inhibition of the xanthine oxidase reaction and the generation of free oxygen radicals.

Key words

Calcium paradox Allopurinol Xanthine oxidase 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Alto LE, Dhalla NS (1979) Myocardial cation contents during induction of calcium paradox. Am J Physiol 237:H713-H719PubMedGoogle Scholar
  2. 2.
    Alto LE, Dhalla NS (1981) Role of changes in microsomal calcium uptake in the effects of reperfusion of Ca2+-deprived rat hearts. Circ Res 48:17–24PubMedGoogle Scholar
  3. 3.
    Akizuki S, Yoshida S, Chambers DE, Eddy LJ, Parmley LF, Yellon DM, Downey JM (1985) Infarct size limitation by the xanthine oxidase inhibitor, allopurinol, in closed-chest dogs with small infarcts. Cardiovasc Res 19:686–692PubMedGoogle Scholar
  4. 4.
    Ashraf M, Onda M, Benedict J, Hirohata Y (1981) Surface ultrastructural features of isolated perfused rat hearts during calcium paradox. Scan Electron Microsc 3:109–114Google Scholar
  5. 5.
    Ashraf M (1986) Role of oxygen free radicals in calcium paradox injury in myocardium. J Mol Cell Cardiol [Suppl 1] 18:182Google Scholar
  6. 6.
    Baker JE, Hearse DJ (1983) Slow calcium channel blockers and the calcium paradox: comparative studies in the rat with seven drugs. J Mol Cell Cardiol 15:475–485PubMedGoogle Scholar
  7. 7.
    Bhattacharya SK, Williams JC, Palnieri GMA (1979) Determination of calcium and magnesium in cardiac and skeletal muscle by atomic absorption spectroscopy using stroichiometric nitrous oxide acetylene flame. Anal Lett 12:1451–1475Google Scholar
  8. 8.
    Boink ABTJ, Ruigrok TJC, Maas AHJ, Zimmerman ANE (1976) Changes in high energy phosphate compounds of isolated rat hearts during Ca2+-free perfusion and reperfusion with Ca2+. J Mol Cell Cardiol 8:973–979PubMedGoogle Scholar
  9. 9.
    Chambers DE, Parks DA, Patterson G, Roy R, McCord JM, Yoshida S, Parmley LF, Downey JM (1985) Xanthine oxidase as a source of free radical damage in myocardial ischemia. J Mol Cell Cardiol 17:145–152PubMedGoogle Scholar
  10. 10.
    Downey J, Chambers D, Roy R, McCord J, Hearse DJ, Yellon DM (1984) Xanthine oxidase-derived free radicals as contributors to early ischemic injury in dog hearts. J Mol Cell Cardiol [Suppl 2] 16:36Google Scholar
  11. 11.
    Frank JS, Langer GA, Nudd LM, Seraydarian K (1977) The myocardial cell surface, its histochemistry and the effect of sialic acid and calcium removal in its structure and cellular ionic exchange. Circ Res 41:702–714PubMedGoogle Scholar
  12. 12.
    Freeman BA, Crapo JD (1982) Free radicals and tissue injury. Lab Invest 47:412–426PubMedGoogle Scholar
  13. 13.
    Greve G, Rotevatn S, Sætersdal T, Øksendal AN, Jynge P (1985) Ultrastructural studies of intercalated disc separations in the rat heart during the calcium paradox. Res Exp Med (Berl) 185:195–206Google Scholar
  14. 14.
    Grinwald PM, Nayler WG (1981) Calcium entry in the calcium paradox. J Mol Cell Cardiol 13:867–880PubMedGoogle Scholar
  15. 15.
    Hearse DJ, Humphrey SM, Boink ABTJ, Ruigrok TJC (1978) The calcium paradox: Metabolic, electrophysiological, contractile and ultrastructural characteristics in four species. Eur J Cardiol 7:241–256PubMedGoogle Scholar
  16. 16.
    Hearse DJ, Humphrey SM, Bullock GR (1978) The oxygen paradox and the calcium paradox: Two facets of the same problem? J Mol Cell Cardiol 10:641–668PubMedGoogle Scholar
  17. 17.
    Hearse DJ, Baker JE, Humphrey SM (1980) Verapamil and the calcium paradox. J Mol Cell Cardiol 12:733–739PubMedGoogle Scholar
  18. 18.
    Hess ML, Manson NH (1984) Molecular oxygen: Friend or foe. The role of the oxygen free radical system in the calcium paradox, the oxygen paradox and ischemia/reperfusion injury. J Mol Cell Cardiol 16:969–985PubMedGoogle Scholar
  19. 19.
    Hülsmann WC (1983) On the mechanism of the calcium paradox: the release of hydrolytic enzymes. Eur Heart J [Suppl H] 4:57–61Google Scholar
  20. 20.
    Julicher RHM, Tijburg LBM, Sterrenberg L, Bast A, Koomen JM, Noordhoek J (1984) Decreased defence against free radicals in rat heart during normal reperfusion after hypoxic, ischemic and calcium-free perfusion. Life Sci 35:1281–1288PubMedGoogle Scholar
  21. 21.
    Kingma JG Jr, Denniss AR, Downey JM, Hearse DJ, Yellon DM (1985) The effect of combination therapy in infarct size limitation in the dog. J Mol Cell Cardiol [Suppl 3] 17:78Google Scholar
  22. 22.
    Koomen JM, Jager LP, van Noordwijk J (1980) Effects of perfusion pressure on coronary flow, myocardial Ca2+-washout, and the ocurrence of calcium paradox in isolated perfused rat heart ventricles. Basic Res Cardiol 75:318–327PubMedGoogle Scholar
  23. 23.
    Krebs HA, Henseleit K (1932) Untersuchungen über die Harnstoffbildung im Tierkörper. Hoppe-Seyler's Z Physiol Chem 210:33–36Google Scholar
  24. 24.
    Langendorff O (1895) Untersuchungen am überlebenden Säugetierherzen. Pflügers Arch Physiol 61:291–332Google Scholar
  25. 25.
    Lebedev AV, Levitsky DO, Loginov VA, Smirnov VN (1982) The effect of primary products of lipid peroxidation on the transmembrane transport of calcium ions. J Mol Cell Cardiol [Suppl 3] 14:99–103Google Scholar
  26. 26.
    McCord JM (1984) Are free radicals a major culprit? In: Hearse DJ, Yellon DM (eds) Therapeutic approaches to myocardial infarct size limitation. Raven Press, New York, pp 209–218Google Scholar
  27. 27.
    Myers CL, Weiss SJ, Kirsh MM, Shlafer M (1985) Involvement of hydrogen peroxide and hydroxyl radical in the “oxygen paradox”: Reduction of creatine kinase release by catalase, allopurinol or deferoxamine, but not by superoxide dismutase. J Mol Cell Cardiol 17:675–684PubMedGoogle Scholar
  28. 28.
    Nayler WG, Elz JS, Perry SE, Daly MJ (1983) The biochemistry of uncontrolled calcium entry. Eur Heart J [Suppl H] 4:29–41Google Scholar
  29. 29.
    Nayler WG, Perry SE, Elz JS, Daly MJ (1984) Calcium, sodium, and the calcium paradox. Circ Res 55:227–237PubMedGoogle Scholar
  30. 30.
    Ohhara H, Kanaide H, Nakamura M (1982) A protective effect of verapamil on the calcium paradox in the isolated perfused rat heart. J Mol Cell Cardiol 14:13–20Google Scholar
  31. 31.
    Perier P, Fabiani JN, Bocher M, Massoud H, Carpentier A, Dubost Ch (1980) Myocardial protection during ischemic cardiac arrest. Hemodynamic studies of the effects of allopurinol in a cardioplegic solution. Arch Mol Coeur 73:713–718Google Scholar
  32. 32.
    Ruigrok TJC, Burgersdijk FJA, Zimmerman ANE (1975) The calcium paradox: A reaffirmation. Eur J Cardiol 3:59–63PubMedGoogle Scholar
  33. 33.
    Ruigrok TJC, Boink ABTJ, Spies F, Blok FJ, Maas AHJ, Zimmerman ANE (1978) Energy dependence of the calcium paradox. J Mol Cell Cardiol 10:991–1002PubMedGoogle Scholar
  34. 34.
    Schaffer SW, Roy RS, McCord JM (1983) Possible role for calmodulin in calcium paradox-induced heart failure. Eur Heart J [Suppl H] 4:81–87Google Scholar
  35. 35.
    Sellevold OFM, Jynge P, Aarstad K (1986) High performance liquid chromatography: a rapid isocratic method for determination of creatine compounds and adenine nucleotides in myocardial tissue. J Mol Cell Cardiol 18:517–527PubMedGoogle Scholar
  36. 36.
    Vusse GJ van der, Reneman RS (1985) Pharmacological intervention in acute myocardial ischemia and reperfusion. Trends Pharmacol Sci 2:76–79Google Scholar
  37. 37.
    Yates JC, Dhalla NS (1975) Structural and functional changes associated with failure and recovery of hearts after perfusion with Ca2+-free medium. J Mol Cell Cardiol 7:91–103PubMedGoogle Scholar
  38. 38.
    Zimmerman ANE, Hülsmann WC (1966) Paradoxical influence of calcium ions on the permeability of the cell membranes of the isolated rat heart. Nature 211:646–647PubMedGoogle Scholar
  39. 39.
    Zimmerman ANE, Daems W, Hülsmann WC, Snijder J, Wisse E, Durrer D (1967) Morphological changes of heart muscle caused by successive perfusion with calcium-free and calcium-containing solutions (calcium paradox). Cardiovasc Res 1:201–209Google Scholar
  40. 40.
    Øksendal AN, Jynge P, Sellevold OFM, Rotevatn S, Sætersdal T (1985) The calcium paradox phenomenon: A flow rate and volume response study of calcium-free perfusion. J Mol Cell Cardiol 17:959–972PubMedGoogle Scholar
  41. 41.
    Øksendal AN, Jynge P (1986) Protection by verapamil in the calcium paradox. Dependence upon micromolar calcium. Cardiovasc Res 20:845–852PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1987

Authors and Affiliations

  • A. N. Øksendal
    • 1
  • K. A. Espnes
    • 1
  • P. Jynge
    • 1
  1. 1.Dept. of Pharmacology and Toxicology, Faculty of MedicineUniversity of TrondheimTrondheimNorway

Personalised recommendations